BioPharma Credit Statistics

Total Valuation

LON:BPCR has a market cap or net worth of GBP 756.24 million. The enterprise value is 752.07 million.

Market Cap	756.24M
Enterprise Value	752.07M

Important Dates

The next estimated earnings date is Wednesday, September 24, 2025.

Earnings Date	Sep 24, 2025
Ex-Dividend Date	Jun 26, 2025

Share Statistics

LON:BPCR has 1.13 billion shares outstanding. The number of shares has decreased by -6.65% in one year.

Current Share Class	1.13B
Shares Outstanding	1.13B
Shares Change (YoY)	-6.65%
Shares Change (QoQ)	-3.81%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	83.64%
Float	993.65M

Valuation Ratios

The trailing PE ratio is 9.02.

PE Ratio	9.02
Forward PE	n/a
PS Ratio	6.31
PB Ratio	0.80
P/TBV Ratio	0.80
P/FCF Ratio	n/a
P/OCF Ratio	8.46
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	7.71
EV / Sales	6.75
EV / EBITDA	n/a
EV / EBIT	8.29
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.09

Current Ratio	2.09
Quick Ratio	2.09
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 9.69% and return on invested capital (ROIC) is 6.05%.

Return on Equity (ROE)	9.69%
Return on Assets (ROA)	5.97%
Return on Invested Capital (ROIC)	6.05%
Return on Capital Employed (ROCE)	10.34%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.12
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.38% in the last 52 weeks. The beta is 0.11, so LON:BPCR's price volatility has been lower than the market average.

Beta (5Y)	0.11
52-Week Price Change	+7.38%
50-Day Moving Average	0.87
200-Day Moving Average	0.87
Relative Strength Index (RSI)	60.17
Average Volume (20 Days)	875,435

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:BPCR had revenue of GBP 119.84 million and earned 97.59 million in profits. Earnings per share was 0.08.

Revenue	119.84M
Gross Profit	119.84M
Operating Income	97.59M
Pretax Income	97.59M
Net Income	97.59M
EBITDA	n/a
EBIT	97.59M
Earnings Per Share (EPS)	0.08

Full Income Statement

Balance Sheet

The company has 4.49 million in cash and n/a in debt, giving a net cash position of 4.49 million or 0.00 per share.

Cash & Cash Equivalents	4.49M
Total Debt	n/a
Net Cash	4.49M
Net Cash Per Share	0.00
Equity (Book Value)	943.89M
Book Value Per Share	0.80
Working Capital	15.60M

Full Balance Sheet

Cash Flow

Operating Cash Flow	89.39M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of 81.44% and 81.44%.

Gross Margin	100.00%
Operating Margin	81.44%
Pretax Margin	81.44%
Profit Margin	81.44%
EBITDA Margin	n/a
EBIT Margin	81.44%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 11.24%.

Dividend Per Share	0.08
Dividend Yield	11.24%
Dividend Growth (YoY)	-2.99%
Years of Dividend Growth	n/a
Payout Ratio	89.23%
Buyback Yield	6.65%
Shareholder Yield	17.91%
Earnings Yield	12.90%
FCF Yield	n/a

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:BPCR has an Altman Z-Score of 37.35 and a Piotroski F-Score of 4.

Altman Z-Score	37.35
Piotroski F-Score	4